Follow @ebcapital
Recent articles
Moderna to Begin Developing a Coronavirus Vaccine
The biotechnology company has been awarded a grant from the Coalition for Epidemic Preparedness Innovations (CEPI) to create a vaccine for the fast-spreading illness.
Pfizer to Market Viagra Through Roman's Telehealth Service
Pfizer's U.S. generic drug subsidiary, Greenstone, is partnering with men's health provider Roman to provide Viagra to patients.
How to Get the Maximum Social Security Benefit
Here's how to pocket the most money possible from Social Security
Jazz Pharma Files for FDA Approval of a New Narcolepsy Drug
The company's submitted an application for approval of JZP-258, a treatment for cataplexy and excessive daytime sleepiness (EDS) in patients with narcolepsy.
Here's Why Community Health Systems Stock Is Surging 13% Higher Today
The hospital operator released preliminary financial results and guidance for 2020.
3 Stocks That Could Be Big Winners if Crude Rallies in 2020
These oil companies could reap the benefits if crude prices jump this year.
Why XBiotech Shares Are Skyrocketing 32.7% Today
The company is offering to buy back shares from investors at a big premium.
Why Adaptimmune Therapeutics Is Jumping 11.5% Today
The clinical-stage company has inked a new deal with a big biopharma.
Why Iovance Biotherapeutics Shares Dropped 11.8% Today
The company announced a string of deals over the weekend that failed to spark investors' optimism.
These 3 Biotech Stocks Could Be Top Stocks in 2020
Fast-approaching catalysts could make these biotech stocks top performers this year.
California's Governor Offers Up New Plan to Spark Legal Marijuana Sales
In a bid to increase legal marijuana sales, Governor Newsom is proposing to overhaul the current regulatory system.
Why Ultragenyx Pharmaceutical Stock Surged 23.4% Today
A promising clinical trial update has investors increasingly optimistic about the company's pipeline.
Why Revance Therapeutics Stock Is Jumping 13.1% Today
A new deal accelerates the company's shift to a commercial-stage biotech.
Here's Why Stericycle's Shares Soared 73.9% in 2019
The company's restructuring strategy appears to be paying off for investors.
Why Axonics Modulation Technologies Is Skyrocketing 24.5% Today
A sneak peek at its fourth-quarter financial performance is fueling investors' optimism.
Why Paylocity Surged 100.7% in 2019
A strong economy fueled double-digit growth at this human resources software company.
Why NuVasive Stock Skyrocketed 56.1% in 2019
Demand for the company's minimally invasive surgical approach continues to outpace the broader spine surgery market.
Why Neurocrine Biosciences Soared 50.5% in 2019
Rapid sales growth for its tardive dyskinesia drug fueled investor optimism.
Why Lumentum Shares Rocketed 88.8% Higher in 2019
The company's 3D sensing technology is increasingly being incorporated into next-generation consumer electronic devices.
Why Antares Pharma's Sliding 10% Today
Investors are locking in gains in this fast-growing drugmaker.